Hints and tips:
Related Special Reports
...“All it takes is one large company like Eli Lilly to do it and then more risk-averse companies follow suit,” he said....
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...Panuwat’s company, Medivation, was bought in 2016 by Pfizer for $14bn. But the stock he purchased at the time was not that of Medivation....
...Any rumours that the company is at risk of defaulting are “flatly untrue”, he said....
...Shockwave’s technology has treated approximately 400,000 patients globally, the company said....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...Our mutual goal needs to be that this will remain the case.”...
...Illumina said the company agreed “with the advocate general that the European Commission’s assertion of jurisdiction over this merger was improper”. Illumina bought Grail in 2021....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...In the past decade, the company rolled out four BlackRock-branded fixed income SMAs and four equity SMAs, according to data from the company’s website....
...Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded....
...Peter Maag, Kyverna chief executive, said it was a “stellar outcome” and that he was particularly encouraged by the level of interest from large generalist mutual fund investors, rather than only healthcare...
...MSIM launched its ETF business a year ago, and in October filed plans to carry out its first mutual fund-to-ETF conversions....
...The company said the security services were “in the interests of the company and its shareholders”, owing to the “critical value” the pair provided....
...In July 2022, the firm secured a €7bn pool to lend to European midmarket companies, the largest fund it has ever raised....
...Franklin Templeton’s experience suggests few investors are bothered about seeing their ownership of a mutual fund on a blockchain....
...ETFs accounted for 51 per cent of underlying assets at the end of last year, up from 46.7 per cent in early 2022, according to data from Broadridge Financial Solutions, a financial technology company, which...
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
Case studies in best practice among general counsel and company legal teams in North America
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
...Buckley initially joined Vanguard as a research assistant to Jack Bogle, the group’s founder, who pioneered passive investing and the company’s unusual mutual structure....
International Edition